BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hui X, Yuan C, Cao W, Ge W, Zhang D, Dan M, Zhao Q, Liu B, Yao B. An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index. OTT 2022;Volume 15:331-43. [DOI: 10.2147/ott.s357326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Najjar MK, Manore SG, Regua AT, Lo HW. Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer. Genes (Basel) 2022;13. [PMID: 36360302 DOI: 10.3390/genes13112065] [Reference Citation Analysis]
2 Cheng-sánchez I, Moya-utrera F, Porras-alcalá C, López-romero JM, Sarabia F. Antibody-Drug Conjugates Containing Payloads from Marine Origin. Marine Drugs 2022;20:494. [DOI: 10.3390/md20080494] [Reference Citation Analysis]